The Michael J. Fox Foundation
Investments
50Portfolio Exits
9Partners & Customers
10The Michael J. Fox Foundation Web Traffic
The Michael J. Fox Foundation Rank
Latest The Michael J. Fox Foundation News
Aug 15, 2022
ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Please try again later. If you continue to have this issue please contact customerservice@slackinc.com . Back to Healio The Michael J. Fox Foundation for Parkinson’s Research has awarded a research grant to health care technology company Koneksa to evaluate Parkinson’s disease progression using digital measures. According to a Koneksa release, the goal of the project is to predict stages of PD using distinct digital measures as classifiers and longitudinally model disease progression. Source: Adobe Stock. “There are no current diagnostics to detect progression in early PD or in the prodromal (pre-diagnostic) stage, and identifying any predictive digital biomarkers would be a meaningful addition for patients and physicians,” Chris Benko, CEO and founder of Koneksa, said in the release. The study will evaluate a retrospective Parkinson’s Progression Markers Initiative (PPMI) dataset from the Verily watch, comprised of digital measures (activity, gait, sleep) using Koneksa algorithms along with the application of specialized machine learning techniques, the release stated. The observational PPMI study is sponsored by the foundation. “The Michael J. Fox Foundation continues to fund research efforts aimed at improving the lives of people with Parkinson’s,” Samantha Hutten, PhD, the foundation’s director of translational research, said in the release. “We are proud to support the work of researchers at Koneksa investigating digital biomarkers to evaluate disease progression, as this is a critical unmet need.” In July 2022, Koneksa received its first research grant from the foundation, in collaboration with Northwestern University, to evaluate a measurement concept designed to objectively quantify the severity of PD symptoms, notably vocal abnormalities related to early stages of disease progression. Read more about
The Michael J. Fox Foundation Investments
50 Investments
The Michael J. Fox Foundation has made 50 investments. Their latest investment was in Koneksa as part of their Grant - II on August 8, 2022.
The Michael J. Fox Foundation Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
8/8/2022 | Grant - II | Koneksa | No | 2 | ||
7/27/2022 | Grant | ZyVersa Therapeutics | Yes | 1 | ||
7/18/2022 | Grant | EpicentRx | $0.5M | Yes | 1 | |
6/16/2022 | Grant | |||||
5/4/2022 | Grant - III |
Date | 8/8/2022 | 7/27/2022 | 7/18/2022 | 6/16/2022 | 5/4/2022 |
---|---|---|---|---|---|
Round | Grant - II | Grant | Grant | Grant | Grant - III |
Company | Koneksa | ZyVersa Therapeutics | EpicentRx | ||
Amount | $0.5M | ||||
New? | No | Yes | Yes | ||
Co-Investors | |||||
Sources | 2 | 1 | 1 |
The Michael J. Fox Foundation Portfolio Exits
9 Portfolio Exits
The Michael J. Fox Foundation has 9 portfolio exits. Their latest portfolio exit was Gain Therapeutics on March 18, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
3/18/2021 | IPO | Public | 4 | ||
Date | 3/18/2021 | ||||
---|---|---|---|---|---|
Exit | IPO | ||||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 4 |
The Michael J. Fox Foundation Partners & Customers
10 Partners and customers
The Michael J. Fox Foundation has 10 strategic partners and customers. The Michael J. Fox Foundation recently partnered with WCG IRB on April 4, 2022.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
4/26/2022 | Vendor | United States | 1 | ||
4/14/2022 | Partner | United States | LYNN , Massachusetts -- Bent Water Brewing will launch Common Hope , a nationwide collaborative initiative designed to raise funds and awareness for Parkinson 's disease . | 1 | |
1/26/2022 | Partner | United States | 1 | ||
10/6/2020 | Partner | ||||
7/16/2020 | Partner |
Date | 4/26/2022 | 4/14/2022 | 1/26/2022 | 10/6/2020 | 7/16/2020 |
---|---|---|---|---|---|
Type | Vendor | Partner | Partner | Partner | Partner |
Business Partner | |||||
Country | United States | United States | United States | ||
News Snippet | LYNN , Massachusetts -- Bent Water Brewing will launch Common Hope , a nationwide collaborative initiative designed to raise funds and awareness for Parkinson 's disease . | ||||
Sources | 1 | 1 | 1 |
The Michael J. Fox Foundation Team
10 Team Members
The Michael J. Fox Foundation has 10 team members, including current Founder, Executive Vice President, Deborah Brooks.
Name | Work History | Title | Status |
---|---|---|---|
Deborah Brooks | Goldman Sachs Asset Management, and Goldman Sachs | Founder, Executive Vice President | Current |
Alex Vannoni | Aetna, Atomic Management, Elemental Machines, Novartis, Cubist Pharmaceuticals, Lieber Institute for Brain Development, Instinct Health Science, Ogilvy & Mather, The Kraft Group, and Major League Baseball | Founder | Current |
Todd Sherer | Chief Executive Officer | Current | |
Holly Teichholtz | Chief Marketing Officer | Current | |
Jim McNasby | Marsh, Mondelez International, Kraft Foods Group, and Davis Polk & Wardwell | Chief People Officer | Current |
Name | Deborah Brooks | Alex Vannoni | Todd Sherer | Holly Teichholtz | Jim McNasby |
---|---|---|---|---|---|
Work History | Goldman Sachs Asset Management, and Goldman Sachs | Aetna, Atomic Management, Elemental Machines, Novartis, Cubist Pharmaceuticals, Lieber Institute for Brain Development, Instinct Health Science, Ogilvy & Mather, The Kraft Group, and Major League Baseball | Marsh, Mondelez International, Kraft Foods Group, and Davis Polk & Wardwell | ||
Title | Founder, Executive Vice President | Founder | Chief Executive Officer | Chief Marketing Officer | Chief People Officer |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.